These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 526719)

  • 21. Human genetic variations in oxidative drug metabolism.
    Xenobiotica; 1986 May; 16(5):359-509. PubMed ID: 3739362
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug concentration in saliva.
    Mucklow JC; Bending MR; Kahn GC; Dollery CT
    Clin Pharmacol Ther; 1978 Nov; 24(5):563-70. PubMed ID: 29738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bio-reduction in the activation of drugs. Proceedings of the Second Biochemical Pharmacology Symposium. Oxford, 25-26 July 1985.
    Biochem Pharmacol; 1986 Jan; 35(1):1-122. PubMed ID: 3940520
    [No Abstract]   [Full Text] [Related]  

  • 24. An experimental model for kinetic preformulation studies on oxidation sensitive substances.
    Fyhr P; Brodin A
    Acta Pharm Suec; 1987; 24(1):15-26. PubMed ID: 3618245
    [No Abstract]   [Full Text] [Related]  

  • 25. [The role of genetically determined oxidation of drugs and xenobiotics in pathogenesis of neoplastic diseases].
    Niewiński P; Orzechowska-Juzwenko K
    Postepy Hig Med Dosw; 1996; 50(4):321-32. PubMed ID: 9019742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatic clearance of drugs in kidney failure].
    Balant L
    Nephrologie; 1983; 4(2):45-7. PubMed ID: 6136004
    [No Abstract]   [Full Text] [Related]  

  • 27. [Heritable polymorphisms in oxidative drug metabolism].
    Kallio J
    Duodecim; 1990; 106(5):408-14. PubMed ID: 1670108
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug displacement from protein-binding and redistributional interactions.
    McQueen EG
    Prog Biochem Pharmacol; 1974; 9():122-8. PubMed ID: 4140531
    [No Abstract]   [Full Text] [Related]  

  • 29. [Induction of drug-catabolizing enzymes in chronic alcoholics].
    Gundert-Remy U; Marquardt R; Andritsch F; Weber E
    Arch Biochem Biophys; 1974 Jan; 160(1):907-8. PubMed ID: 4828518
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacokinetics in liver cirrhosis].
    Ackermann E
    Z Gesamte Inn Med; 1977 Jan; 32(1):29-33. PubMed ID: 855389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genetically determined abnormal reactions to drugs].
    Prandota J; Iwańczak F; Panków-Prandota L
    Pediatr Pol; 1980 Apr; 55(4):525-30. PubMed ID: 6997825
    [No Abstract]   [Full Text] [Related]  

  • 32. [Inter-individual differences in pharmacokinetics in humans: clinical importance].
    Sjöqvist F
    Minerva Med; 1973 Mar; 64(17):866-79. PubMed ID: 4703858
    [No Abstract]   [Full Text] [Related]  

  • 33. Innovative oxidation methods in fine chemicals synthesis.
    Poechlauer P; Skranc W
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):1000-8. PubMed ID: 12478730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings: The effect of triiodinated radiographic contrast media on microsomal drug metabolism.
    Hüthwohl B; Hohage H; Trüber E
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R79. PubMed ID: 1143497
    [No Abstract]   [Full Text] [Related]  

  • 35. [In vitro tests of hepatic oxidation in man, predictive of drug interactions].
    Dayer P; Leemann T; Striberni R; Meyer P
    Schweiz Med Wochenschr; 1987 Dec; 117(49):1971-3. PubMed ID: 3423780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substrate-metabolite profiles in the study of inter-individual differences in drug oxidation in man [proceedings].
    Boobis AR; Brodie MJ; Davies DS; Murray S; Toverud EL
    Br J Clin Pharmacol; 1979 Apr; 7(4):415P-416P. PubMed ID: 444365
    [No Abstract]   [Full Text] [Related]  

  • 37. Obesity and fasting--effects on drug metabolism and drug action in man.
    Reidenberg MM
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 2):729-34. PubMed ID: 913031
    [No Abstract]   [Full Text] [Related]  

  • 38. Polymorphic drug oxidation--much ado about nothing?
    Lancet; 1984 Jun; 1(8390):1337. PubMed ID: 6145034
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic evidence for the involvement of different oxidative mechanisms in drug oxidation.
    Wakile LA; Sloan TP; Idle JR; Smith RL
    J Pharm Pharmacol; 1979 May; 31(5):350-2. PubMed ID: 37314
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetically determined variability in drug metabolism: dual slow acetylation and drug oxidation traits.
    Mahgoub A; Idle JR; Smith RL
    Lancet; 1979 Jul; 2(8134):154. PubMed ID: 88594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.